{"meta":{"humanUrl":"https://us-uk.bookimed.com/clinics/country=china/city=chengdu/procedure=immunotherapy/","canonicalUrl":"https://us-uk.bookimed.com/clinics/country=china/city=chengdu/procedure=immunotherapy/","jsonUrl":"https://us-uk.bookimed.com/clinics/country=china/city=chengdu/procedure=immunotherapy/data.json","title":"Immunotherapy Clinics in Chengdu 2026: Cost, Clinics & Reviews","description":"Immunotherapy in Chengdu costs from $3,000. Compare 1 , verified reviews. Get your free quote!","heading":"Immunotherapy in Chengdu — Get 3 Top Clinic Matches with Costs","locale":"en","schemaVersion":"ClinicListingPageDataV1","snapshotId":"ad3d5f2a-6f069c7e","contentVersion":"ad3d5f2a","generatedAt":"2026-11-22T15:41:27.548Z"},"filters":{"country":"china","city":"chengdu","procedure":"immunotherapy","page":1},"pagination":{"page":1,"totalCount":1,"totalPages":1},"breadcrumbs":[{"name":"Home","url":"/"},{"name":"Clinics","url":"/clinics/"},{"name":"China","url":"/clinics/country=china/"},{"name":"Chengdu","url":"/clinics/country=china/city=chengdu/"},{"name":"Immunotherapy","url":"/clinics/country=china/procedure=immunotherapy/"}],"entities":[{"name":"China","alias":"china","type":"country","id":203},{"name":"Chengdu","alias":"chengdu","type":"city","id":2693},{"name":"Immunotherapy","alias":"immunotherapy","type":"procedure","id":283}],"clinics":{"clinics":[{"text":"<p>Uni-Asia Cancer Hospital treats 20,000+ patients every year using a multidisciplinary approach. The medical team specializes in combining immune checkpoint inhibitors with local therapies like NanoKnife or cryoablation for refractory tumors. Treatment plans are personalized based on PD-L1 expression testing to improve precision. Dr. Luo Jiamin leads these complex strategies, focusing on advanced lung and liver cancers. The facility offers 80 hotel-standard private rooms and full-course management from the first consultation through follow-up care.</p>","text_type":"mt_wow_description","best_texts":{"techniques":"Immune checkpoint inhibitors, biomarker-based stratification","good_fit_for":"Advanced or treatment-resistant solid tumors"},"agency_settings":[{"setting_name":"is_new","setting_value":"1"},{"setting_name":"kids_only","setting_value":"0"}],"procedure_prices":[{"prices":{"price_from":3000,"price_to":0,"currency":"USD","id":58766},"operation":{"id":283,"name":"Immunotherapy","alias":"immunotherapy"}},{"prices":{"price_from":100,"price_to":200,"currency":"USD","id":58456},"diagnostic":{"id":523,"name":"Online Consultation with Oncologist","alias":"online-consultation-with-oncologist"}},{"prices":{"price_from":1310,"price_to":1310,"currency":"USD","id":57939},"diagnostic":{"id":1,"name":"PET/CT","alias":"pet-ct"}}],"reviews":[],"clinic":{"id":8327,"alias":"uni-asia-hospital","name":"Uni-asia Cancer hospital","short_description":"<p>Uni-asia Cancer Hospital is a private single-specialty medical center located in Chengdu, China, dedicated to oncology, including interventional therapy for liver cancer. A patient with liver cancer achieved complete recovery following interventional therapy at the hospital, an exceptionally rare outcome documented in the medical records.</p><p>Uni-asia Cancer Hospital serves adults only and treats 20,000 patients every year, with patients coming most often from Arab League states, Europe, and the United States.</p>","images":[{"base_url":"clinic/6a6964fa14866","title":"Clinic facade of Uni-Asia Cancer Hospital with modern exterior and landscaped greenery"},{"base_url":"clinic/6a6966d0194c1","title":"Waiting area at Uni-asia Cancer Hospital with modern seating and large windows"},{"base_url":"clinic/6a6966fc54607","title":"Uni-asia Cancer Hospital exterior wall with slogan and panda statues"},{"base_url":"clinic/6a696726f0bc9","title":"Patient room at Uni-asia Cancer Hospital with modern bed and sofa"}],"flags":[{"name":"has_active_agencies","value":true},{"name":"is_hide","value":false}],"geo":{"country":{"name":"China","id":203,"alias":"china","iso_code":"CN"},"city":{"name":"Chengdu","id":2693,"alias":"chengdu"},"address":"China, Si Chuan Sheng, Cheng Du Shi, Cheng Hua Qu, Huai Shu Dian Lu, 40-268号成都汇康中西医结合医院 邮政编码: 610058"},"rating":{"rating":0,"google":4.5,"percent_of_satisfied_clients":0},"statistics":{"number_of_reviews":0,"doctors_number":25,"year_foundation":2011},"accreditations":[],"agency_settings":[{"setting_name":"is_new","setting_value":"1"},{"setting_name":"kids_only","setting_value":"0"}]}}],"meta":{"total_count":1,"total_pages":1}},"clinicsMeta":{"total_count":1,"total_pages":1},"clinicsCount":1,"clinicsCountByEntity":{"clinic_count":143},"doctors":{"doctors":[{"doctor":{"id":13907,"alias":"liao-zhengyin","name":"Liao Zhengyin","clinic_id":8327,"photo":"doctor/6a697a03af34c","first_year_working":1991,"created_at":"2026-07-29T03:56:48.904+00:00","short_description":"<p>Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.</p>\n<p>Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.</p>\n<p>Leads 2 provincial S&amp;T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.</p>","specialities":[{"id":"onc.001","name":"Clinical oncologist","illness_kind_id":10},{"id":"onc.002","name":"Gynecologic oncologist","illness_kind_id":10},{"id":"onc.003","name":"Orthopedic oncologist","illness_kind_id":10},{"id":"onc.004","name":"Neurooncologist","illness_kind_id":10}],"statistics":{"operations_performed_count":100000}},"clinic":{"id":8327,"alias":"uni-asia-hospital","name":"Uni-asia Cancer hospital","short_description":"<p>Uni-asia Cancer Hospital is a private single-specialty medical center located in Chengdu, China, dedicated to oncology, including interventional therapy for liver cancer. A patient with liver cancer achieved complete recovery following interventional therapy at the hospital, an exceptionally rare outcome documented in the medical records.</p><p>Uni-asia Cancer Hospital serves adults only and treats 20,000 patients every year, with patients coming most often from Arab League states, Europe, and the United States.</p>","images":[{"base_url":"clinic/6a6964fa14866","title":"Clinic facade of Uni-Asia Cancer Hospital with modern exterior and landscaped greenery"},{"base_url":"clinic/6a6966d0194c1","title":"Waiting area at Uni-asia Cancer Hospital with modern seating and large windows"},{"base_url":"clinic/6a6966fc54607","title":"Uni-asia Cancer Hospital exterior wall with slogan and panda statues"},{"base_url":"clinic/6a696726f0bc9","title":"Patient room at Uni-asia Cancer Hospital with modern bed and sofa"}],"flags":[{"name":"has_active_agencies","value":true},{"name":"is_hide","value":false}],"geo":{"country":{"name":"China","id":203,"alias":"china","iso_code":"CN"},"city":{"name":"Chengdu","id":2693,"alias":"chengdu"},"address":"China, Si Chuan Sheng, Cheng Du Shi, Cheng Hua Qu, Huai Shu Dian Lu, 40-268号成都汇康中西医结合医院 邮政编码: 610058"},"rating":{"rating":0,"google":4.5,"percent_of_satisfied_clients":0},"statistics":{"number_of_reviews":0,"doctors_number":25,"year_foundation":2011},"accreditations":[]},"procedure_prices":[{"prices":{"price_from":3000,"price_to":0,"currency":"USD","id":58766},"operation":{"id":283,"name":"Immunotherapy","alias":"immunotherapy"}}]},{"doctor":{"id":15269,"alias":"luo-xiaoping","name":"Luo Xiaoping","clinic_id":8327,"photo":"doctor/6a73f584b563f","first_year_working":1985,"created_at":"2026-08-06T02:46:25.456+00:00","short_description":"<p>Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.</p>\n<p>He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).</p>","specialities":[{"id":"onc.001","name":"Clinical oncologist","illness_kind_id":10},{"id":"onc.002","name":"Gynecologic oncologist","illness_kind_id":10},{"id":"onc.003","name":"Orthopedic oncologist","illness_kind_id":10},{"id":"onc.004","name":"Neurooncologist","illness_kind_id":10}],"statistics":{}},"clinic":{"id":8327,"alias":"uni-asia-hospital","name":"Uni-asia Cancer hospital","short_description":"<p>Uni-asia Cancer Hospital is a private single-specialty medical center located in Chengdu, China, dedicated to oncology, including interventional therapy for liver cancer. A patient with liver cancer achieved complete recovery following interventional therapy at the hospital, an exceptionally rare outcome documented in the medical records.</p><p>Uni-asia Cancer Hospital serves adults only and treats 20,000 patients every year, with patients coming most often from Arab League states, Europe, and the United States.</p>","images":[{"base_url":"clinic/6a6964fa14866","title":"Clinic facade of Uni-Asia Cancer Hospital with modern exterior and landscaped greenery"},{"base_url":"clinic/6a6966d0194c1","title":"Waiting area at Uni-asia Cancer Hospital with modern seating and large windows"},{"base_url":"clinic/6a6966fc54607","title":"Uni-asia Cancer Hospital exterior wall with slogan and panda statues"},{"base_url":"clinic/6a696726f0bc9","title":"Patient room at Uni-asia Cancer Hospital with modern bed and sofa"}],"flags":[{"name":"has_active_agencies","value":true},{"name":"is_hide","value":false}],"geo":{"country":{"name":"China","id":203,"alias":"china","iso_code":"CN"},"city":{"name":"Chengdu","id":2693,"alias":"chengdu"},"address":"China, Si Chuan Sheng, Cheng Du Shi, Cheng Hua Qu, Huai Shu Dian Lu, 40-268号成都汇康中西医结合医院 邮政编码: 610058"},"rating":{"rating":0,"google":4.5,"percent_of_satisfied_clients":0},"statistics":{"number_of_reviews":0,"doctors_number":25,"year_foundation":2011},"accreditations":[]},"procedure_prices":[{"prices":{"price_from":3000,"price_to":0,"currency":"USD","id":58766},"operation":{"id":283,"name":"Immunotherapy","alias":"immunotherapy"}}]},{"doctor":{"id":15283,"alias":"he-weibing","name":"He Weibing","clinic_id":8327,"photo":"doctor/6a7428d24a767","first_year_working":2000,"created_at":"2026-08-06T06:25:18.729+00:00","short_description":"<p>Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.</p>\n<p>He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.</p>","specialities":[{"id":"onc.001","name":"Clinical oncologist","illness_kind_id":10},{"id":"onc.002","name":"Gynecologic oncologist","illness_kind_id":10},{"id":"onc.003","name":"Orthopedic oncologist","illness_kind_id":10},{"id":"onc.004","name":"Neurooncologist","illness_kind_id":10}],"statistics":{}},"clinic":{"id":8327,"alias":"uni-asia-hospital","name":"Uni-asia Cancer hospital","short_description":"<p>Uni-asia Cancer Hospital is a private single-specialty medical center located in Chengdu, China, dedicated to oncology, including interventional therapy for liver cancer. A patient with liver cancer achieved complete recovery following interventional therapy at the hospital, an exceptionally rare outcome documented in the medical records.</p><p>Uni-asia Cancer Hospital serves adults only and treats 20,000 patients every year, with patients coming most often from Arab League states, Europe, and the United States.</p>","images":[{"base_url":"clinic/6a6964fa14866","title":"Clinic facade of Uni-Asia Cancer Hospital with modern exterior and landscaped greenery"},{"base_url":"clinic/6a6966d0194c1","title":"Waiting area at Uni-asia Cancer Hospital with modern seating and large windows"},{"base_url":"clinic/6a6966fc54607","title":"Uni-asia Cancer Hospital exterior wall with slogan and panda statues"},{"base_url":"clinic/6a696726f0bc9","title":"Patient room at Uni-asia Cancer Hospital with modern bed and sofa"}],"flags":[{"name":"has_active_agencies","value":true},{"name":"is_hide","value":false}],"geo":{"country":{"name":"China","id":203,"alias":"china","iso_code":"CN"},"city":{"name":"Chengdu","id":2693,"alias":"chengdu"},"address":"China, Si Chuan Sheng, Cheng Du Shi, Cheng Hua Qu, Huai Shu Dian Lu, 40-268号成都汇康中西医结合医院 邮政编码: 610058"},"rating":{"rating":0,"google":4.5,"percent_of_satisfied_clients":0},"statistics":{"number_of_reviews":0,"doctors_number":25,"year_foundation":2011},"accreditations":[]},"procedure_prices":[{"prices":{"price_from":3000,"price_to":0,"currency":"USD","id":58766},"operation":{"id":283,"name":"Immunotherapy","alias":"immunotherapy"}}]},{"doctor":{"id":13922,"alias":"xiao-yueyong","name":"Xiao Yueyong","clinic_id":8327,"photo":"doctor/6a69c01738e84","first_year_working":1991,"created_at":"2026-07-29T08:55:44.300+00:00","short_description":"<p>Professor Xiao Yueyong is Chief Physician in the Department of Radiological Diagnosis at the Chinese PLA General Hospital. He is a leading expert in minimally invasive interventional oncology. He serves as the inaugural President of WATA (2025–). He is President of the International (2020–) and Asian (2012–) Societies of Cryotherapy. He is also Deputy Head of the NHC Expert Group on tumour ablation regulations (2009–).</p>\n<p>He has performed over 100,000 CT/MRI‑guided minimally invasive procedures. His work covers chemical ablation, RFA, MWA, cryoablation, and NanoKnife (IRE). He introduced and advanced NanoKnife ablation in China. He led the first national standards for tumour cryoablation and NanoKnife.</p>\n<p>Honors include the National Special Contribution Award (Lifetime Honorary). He received First Prize from the Chinese Medicine Education Association (2021). He received two Second Prizes for Military Medical Achievements (2016, 2018) and two Second Prizes from the China Anti‑Cancer Association (2019, 2022). He was named Asian Ablation Master. His research record includes 13 Chinese patents. He is the principal investigator for four NSFC projects and one MOST subject. He has published over 200 papers, with over 110 as first or corresponding author and over 40 in SCI journals. He has led over 10 ablation guidelines or consensus statements.</p>","specialities":[{"id":"onc.001","name":"Clinical oncologist","illness_kind_id":10},{"id":"onc.002","name":"Gynecologic oncologist","illness_kind_id":10},{"id":"onc.003","name":"Orthopedic oncologist","illness_kind_id":10},{"id":"onc.004","name":"Neurooncologist","illness_kind_id":10}],"statistics":{}},"clinic":{"id":8327,"alias":"uni-asia-hospital","name":"Uni-asia Cancer hospital","short_description":"<p>Uni-asia Cancer Hospital is a private single-specialty medical center located in Chengdu, China, dedicated to oncology, including interventional therapy for liver cancer. A patient with liver cancer achieved complete recovery following interventional therapy at the hospital, an exceptionally rare outcome documented in the medical records.</p><p>Uni-asia Cancer Hospital serves adults only and treats 20,000 patients every year, with patients coming most often from Arab League states, Europe, and the United States.</p>","images":[{"base_url":"clinic/6a6964fa14866","title":"Clinic facade of Uni-Asia Cancer Hospital with modern exterior and landscaped greenery"},{"base_url":"clinic/6a6966d0194c1","title":"Waiting area at Uni-asia Cancer Hospital with modern seating and large windows"},{"base_url":"clinic/6a6966fc54607","title":"Uni-asia Cancer Hospital exterior wall with slogan and panda statues"},{"base_url":"clinic/6a696726f0bc9","title":"Patient room at Uni-asia Cancer Hospital with modern bed and sofa"}],"flags":[{"name":"has_active_agencies","value":true},{"name":"is_hide","value":false}],"geo":{"country":{"name":"China","id":203,"alias":"china","iso_code":"CN"},"city":{"name":"Chengdu","id":2693,"alias":"chengdu"},"address":"China, Si Chuan Sheng, Cheng Du Shi, Cheng Hua Qu, Huai Shu Dian Lu, 40-268号成都汇康中西医结合医院 邮政编码: 610058"},"rating":{"rating":0,"google":4.5,"percent_of_satisfied_clients":0},"statistics":{"number_of_reviews":0,"doctors_number":25,"year_foundation":2011},"accreditations":[]},"procedure_prices":[{"prices":{"price_from":3000,"price_to":0,"currency":"USD","id":58766},"operation":{"id":283,"name":"Immunotherapy","alias":"immunotherapy"}}]},{"doctor":{"id":13921,"alias":"zhang-jinshan","name":"Zhang Jinshan","clinic_id":8327,"photo":"doctor/6a69babae5863","first_year_working":1985,"created_at":"2026-07-29T08:32:55.580+00:00","description":"<p>Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.</p><p style=\"margin-left:0px;\">1980–1985: Completed doctoral studies at Nagasaki University, Japan</p><p style=\"margin-left:0px;\">1968–present: Department of Radiology, Chinese PLA General Hospital</p><p style=\"margin-left:0px;\">1988: Third Prize of the Military Science and Technology Progress Award</p><p style=\"margin-left:0px;\">1989–present: Member of Radiological Society of North America(RSNA)</p><p style=\"margin-left:0px;\">1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA</p><p style=\"margin-left:0px;\">1991: Second Prize of the Military Science and Technology Progress Award</p><p style=\"margin-left:0px;\">1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology</p><p style=\"margin-left:0px;\">1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology</p><p style=\"margin-left:0px;\">1993: Granted the Lifetime Special Government Allowance of the State Council</p><p style=\"margin-left:0px;\">1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology</p><p style=\"margin-left:0px;\">1994: Third Prize of the Military Science and Technology Progress Award</p><p style=\"margin-left:0px;\">1997: Second Prize of the Military Science and Technology Progress Award</p><p style=\"margin-left:0px;\">1997–2009: Standing Member of Chinese Society of Radiology</p><p style=\"margin-left:0px;\">1999: Third Prize of the Military Science and Technology Progress Award</p><p style=\"margin-left:0px;\">1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology</p><p style=\"margin-left:0px;\">2002: Second Prize of the Military Science and Technology Progress Award</p><p style=\"margin-left:0px;\">2005: Third Prize of the Military Science and Technology Progress Award</p><p style=\"margin-left:0px;\">Member of Radiological Society of North America(RSNA)</p><p style=\"margin-left:0px;\">Standing Member of Chinese Society of Radiology</p><p style=\"margin-left:0px;\">Group Leader of the Group of Intervention of Chinese Journal of Radiology</p><p style=\"margin-left:0px;\">Deputy Director Member of Chinese Society of Interventional Oncology</p><p style=\"margin-left:0px;\">Director Member of Beijing Medical Association Society of Interventional Radiology</p><p style=\"margin-left:0px;\">Deputy Chief Editor of Chinese Journal of Medical Image Technology</p><p style=\"margin-left:0px;\">Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army</p><p style=\"margin-left:0px;\">Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology</p><p style=\"margin-left:0px;\">Awarded the Special Government Allowance of the State Council</p><p style=\"margin-left:0px;\">Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.</p><p style=\"margin-left:0px;\">Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”</p><p style=\"margin-left:0px;\">Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.</p><p style=\"margin-left:0px;text-align:justify;\">In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.</p><img src=\"https://huan-ya.oss-ap-southeast-1.aliyuncs.com/media/mpp3o2my-3d1951d6.jpg\" alt=\"zhang-jin-shan\" /><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.</p><img src=\"https://huan-ya.oss-ap-southeast-1.aliyuncs.com/media/mpp3rdgs-a13c877f.jpg\" alt=\"zhang-jin-shan\" /><p style=\"margin-left:0px;text-align:justify;\">In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.</p><img src=\"https://huan-ya.oss-ap-southeast-1.aliyuncs.com/media/mpp3rsxb-30a7dc56.jpg\" alt=\"zhang-jin-shan\" /><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.</p><img src=\"https://huan-ya.oss-ap-southeast-1.aliyuncs.com/media/mpp3s6j1-ffdc9bd7.jpg\" alt=\"zhang-jin-shan\" /><p style=\"margin-left:0px;text-align:justify;\">From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion\". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.</p><h3 style=\"margin-left:0px;\"><strong>Professor Zhang Jinshan’s Academic Achievements</strong></h3><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.</p><h4 style=\"margin-left:0px;\"><strong>Selected Publications by Professor Zhang Jinshan</strong></h4><p style=\"margin-left:0px;text-align:justify;\">1. <strong>Zhang Jinshan, Wang Maoqiang. </strong><i><strong>Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology</strong></i><strong>, 1993，27（6）：361-365.</strong></p><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.</p><p style=\"margin-left:0px;text-align:justify;\"><strong>2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.</strong><i><strong>Chinese Journal of Radiology</strong></i><strong>, 1996，30（8）：521-524.</strong></p><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan is the first author. He innovatively proposed the technique of \"transcatheter arterial embolization with temporary hepatic vein occlusion.\" Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.</p><p style=\"margin-left:0px;text-align:justify;\"><strong>3. Zhang Jinshan, Wang Maoqiang, Li Huai. </strong>Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, <strong>1998，14（3）：189-191.</strong></p><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.</p><p style=\"margin-left:0px;text-align:justify;\"><strong>4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. </strong><i><strong>Chinese Journal of Radiology</strong></i><strong>, 2000，34（5）：335-337.</strong></p><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.</p><p style=\"margin-left:0px;text-align:justify;\"><strong>5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.</strong><i><strong>Chinese Journal of Radiology</strong></i><strong>, 2002，36（7）：612-614.</strong></p><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.</p><p style=\"margin-left:0px;text-align:justify;\"><strong>6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. </strong>Chinese Journal of Medical Imaging Technology, <strong>2004，20（9）：1395-1397.</strong></p><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.</p><p style=\"margin-left:0px;text-align:justify;\"><strong>7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. </strong><i><strong>Chinese Journal of Radiology, </strong></i><strong>2006，40（8）：876-878.</strong></p><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.</p><p style=\"margin-left:0px;text-align:justify;\"><strong>8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.</strong></p><p style=\"margin-left:0px;text-align:justify;\">Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.</p><h4 style=\"margin-left:0px;\"><strong>Professor Zhang Jinshan co-authored monographs</strong></h4><p style=\"margin-left:0px;text-align:justify;\">1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.</p><p style=\"margin-left:0px;text-align:justify;\">2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.</p><p style=\"margin-left:0px;text-align:justify;\">3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.</p><h4 style=\"margin-left:0px;\"><strong>Professor Zhang Jinshan’s Research project</strong></h4><p style=\"margin-left:0px;text-align:justify;\">1.The National \"Eighth Five-Year Plan\" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.</p><p style=\"margin-left:0px;text-align:justify;\">2.The Military \"Ninth Five-Year Plan\" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.</p><p style=\"margin-left:0px;text-align:justify;\">3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.</p><p style=\"margin-left:0px;text-align:justify;\">4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.</p>","specialities":[{"id":"onc.001","name":"Clinical oncologist","illness_kind_id":10},{"id":"onc.002","name":"Gynecologic oncologist","illness_kind_id":10},{"id":"onc.003","name":"Orthopedic oncologist","illness_kind_id":10},{"id":"onc.004","name":"Neurooncologist","illness_kind_id":10}],"statistics":{"operations_performed_count":50000}},"clinic":{"id":8327,"alias":"uni-asia-hospital","name":"Uni-asia Cancer hospital","short_description":"<p>Uni-asia Cancer Hospital is a private single-specialty medical center located in Chengdu, China, dedicated to oncology, including interventional therapy for liver cancer. A patient with liver cancer achieved complete recovery following interventional therapy at the hospital, an exceptionally rare outcome documented in the medical records.</p><p>Uni-asia Cancer Hospital serves adults only and treats 20,000 patients every year, with patients coming most often from Arab League states, Europe, and the United States.</p>","images":[{"base_url":"clinic/6a6964fa14866","title":"Clinic facade of Uni-Asia Cancer Hospital with modern exterior and landscaped greenery"},{"base_url":"clinic/6a6966d0194c1","title":"Waiting area at Uni-asia Cancer Hospital with modern seating and large windows"},{"base_url":"clinic/6a6966fc54607","title":"Uni-asia Cancer Hospital exterior wall with slogan and panda statues"},{"base_url":"clinic/6a696726f0bc9","title":"Patient room at Uni-asia Cancer Hospital with modern bed and sofa"}],"flags":[{"name":"has_active_agencies","value":true},{"name":"is_hide","value":false}],"geo":{"country":{"name":"China","id":203,"alias":"china","iso_code":"CN"},"city":{"name":"Chengdu","id":2693,"alias":"chengdu"},"address":"China, Si Chuan Sheng, Cheng Du Shi, Cheng Hua Qu, Huai Shu Dian Lu, 40-268号成都汇康中西医结合医院 邮政编码: 610058"},"rating":{"rating":0,"google":4.5,"percent_of_satisfied_clients":0},"statistics":{"number_of_reviews":0,"doctors_number":25,"year_foundation":2011},"accreditations":[]},"procedure_prices":[{"prices":{"price_from":3000,"price_to":0,"currency":"USD","id":58766},"operation":{"id":283,"name":"Immunotherapy","alias":"immunotherapy"}}]}],"meta":{"total_count":5,"total_pages":1}},"reviews":{"reviews":[{"id":20142,"user":{"id":750022,"name":"Andrey ","country_code":"KZ","country_name":{"en":"Kazakhstan"}},"ratings":[{"name":"main","value":5},{"name":"relative_price","value":2},{"name":"doctor","value":5},{"name":"personal","value":5},{"name":"comfort","value":5},{"name":"coordination","value":5},{"name":"translation","value":5},{"name":"nps","value":10},{"name":"manager","value":5}],"text":{"en":"I chose this clinic after reading and looking at reviews. High-tech equipment and the approach of doctors, according to reviews in clinics in other countries offered removal of an organ such as kidney, in this clinic on the contrary to do everything possible to save, so I decided, in my country and in neighbouring Russia I could not make a diagnosis or explain what is there, suspicion of neoplasm, but I did not get a specific answer after all the examinations, here in Fuda clarified everything and explained in detail, made a complete examination, equipment is high level, in general satisfied with everything, p Therefore, I can safely recommend it."},"order":{"operation":{"id":110,"name":{"en":"CyberKnife"}},"illness":{"id":7,"name":{"en":"Pancreatic cancer"}}},"clinic_info":{"id":436,"name":"Fuda Cancer Hospital","alias":"fuda-hospital","flags":[{"name":"is_hide","value":false},{"name":"has_active_agencies","value":true}]},"created_at":"2025-05-27T13:58:39.422+00:00","flags":[{"name":"is_approved","value":true},{"name":"has_client_feedback","value":true},{"name":"is_anonymously","value":true},{"name":"would_recommend","value":true},{"name":"is_notification_sent","value":false},{"name":"coordinator_mentioned","value":true},{"name":"deactivated_clinic","value":false}],"images":[{"full_url":"review/6835cb9078ea6_b.jpeg","preview_url":"review/6835cb9078ea6_s.jpeg"},{"full_url":"review/6835cb9104fef_b.jpeg","preview_url":"review/6835cb9104fef_s.jpeg"},{"full_url":"review/6835cb9157fe1_b.jpeg","preview_url":"review/6835cb9157fe1_s.jpeg"}],"client_response":{"preview_to_review_text":{"en":"I chose this clinic after reading and looking at reviews. High-tech equipment and the approach of doctors, according to reviews in clinics in other countries offered removal of an organ such as kidney, in this clinic on the contrary to do everything possible to save, so I decided, in my country and in neighbouring Russia I could not make a diagnosis or explain what is there, suspicion of neoplasm, but I did not get a specific answer after all the examinations, here in Fuda clarified everything and explained in detail, made a complete examination, equipment is high level, in general satisfied with everything, p Therefore, I can safely recommend it."},"what_like_text":{"en":"When the test results came back and the doctor was happy to tell me everything was fine."},"what_not_like_text":{"en":"It's basically fine."}},"comment_about_bookimed":{"en":"I found out about the clinic by calling bookimed Julia explained everything very well and in detail. She organised my trip, was in touch with me all the time, supported me if I had any doubts and thanked me very much."},"summary":{"positive":{"en":"In general satisfied with everything, Therefore, I can safely recommend it."}}},{"id":6754,"user":{"id":162092,"name":"Анна ","country_code":"RU"},"ratings":[{"name":"main","value":5},{"name":"comfort","value":5},{"name":"coordination","value":5},{"name":"doctor","value":5},{"name":"manager","value":0},{"name":"personal","value":5},{"name":"translation","value":0},{"name":"relative_price","value":0}],"text":{"en":"In principle, the visit went very well, only good impressions remained. Now there are certain problems, because doctors at home do not agree with the diagnosis that was made in China, but we were provided with professional help at the Food Clinic. Despite the fact that the full-time translator was on vacation and we took it on our own, the visit went very well. The rooms are very good, they look like 5 star rooms. As soon as we arrived, the nurses came to the ward, measured the pressure, helped in everything. In general, the clinic staff is friendly and helpful."},"order":{"illness":{"id":2238,"name":{"en":"Liver cancer stage 4"}}},"clinic_info":{"id":436,"name":"Fuda Cancer Hospital","alias":"fuda-hospital","flags":[{"name":"is_hide","value":false},{"name":"has_active_agencies","value":true}]},"created_at":"2020-02-20T10:30:29.000+00:00","flags":[{"name":"is_approved","value":true},{"name":"is_anonymously","value":false},{"name":"is_notification_sent","value":true},{"name":"would_recommend","value":false},{"name":"has_client_feedback","value":true},{"name":"deactivated_clinic","value":false}],"summary":{"positive":{"en":"\"In principle, the visit went very well, only good impressions remained.\""}}},{"id":6261,"user":{"id":154564,"name":"Анжелика ","country_code":"RU"},"ratings":[{"name":"main","value":5},{"name":"comfort","value":5},{"name":"coordination","value":5},{"name":"doctor","value":5},{"name":"manager","value":5},{"name":"personal","value":5},{"name":"translation","value":4},{"name":"relative_price","value":3}],"text":{"en":"The stay went well, the doctor and staff inspire confidence. The ward is good, the main thing is that the attendant can always be with the patient. Given that Russia has refused us, we are very grateful to the Food Clinic and Bookimed for their care, for the hope given."},"order":{"illness":{"id":2226,"name":{"en":"Colon cancer stage 4"}},"diagnostic":{"id":102,"name":{"en":"Consultation with an oncologist"}}},"clinic_info":{"id":436,"name":"Fuda Cancer Hospital","alias":"fuda-hospital","flags":[{"name":"is_hide","value":false},{"name":"has_active_agencies","value":true}]},"created_at":"2019-12-31T10:51:41.000+00:00","flags":[{"name":"is_approved","value":true},{"name":"is_anonymously","value":false},{"name":"is_notification_sent","value":true},{"name":"would_recommend","value":true},{"name":"has_client_feedback","value":true},{"name":"deactivated_clinic","value":false}],"comment_about_bookimed":{"en":"THANK YOU"},"summary":{"positive":{"en":"We are very grateful to the Food Clinic and Bookimed for their care, for the hope given."}}},{"id":5475,"user":{"id":107947,"name":"Othman Faraj","country_code":"GB","country_name":{"en":"United Kingdom"}},"ratings":[{"name":"main","value":4},{"name":"comfort","value":3},{"name":"coordination","value":4},{"name":"doctor","value":4},{"name":"manager","value":4},{"name":"personal","value":4},{"name":"translation","value":4},{"name":"relative_price","value":3}],"text":{"en":"The bookimed support was OK but not adequate."},"order":{"illness":{"id":99,"name":{"en":"Sarcoma"}},"diagnostic":{"id":274,"name":{"en":"CT of thoracic, abdominal and pelvic organs"}}},"clinic_info":{"id":436,"name":"Fuda Cancer Hospital","alias":"fuda-hospital","flags":[{"name":"is_hide","value":false},{"name":"has_active_agencies","value":true}]},"created_at":"2019-10-07T10:43:00.000+00:00","flags":[{"name":"is_approved","value":true},{"name":"is_anonymously","value":true},{"name":"is_notification_sent","value":false},{"name":"would_recommend","value":true},{"name":"has_client_feedback","value":true},{"name":"deactivated_clinic","value":false}],"comment_about_bookimed":{"en":"The bookimed support was OK but not adequate."},"summary":{"positive":{"en":"The doctor was extremely knowledgeable and experienced."}}},{"id":6482,"user":{"id":155804,"name":"Надежда ","country_code":"BY"},"ratings":[{"name":"main","value":4},{"name":"comfort","value":5},{"name":"coordination","value":5},{"name":"doctor","value":5},{"name":"manager","value":5},{"name":"personal","value":5},{"name":"translation","value":5},{"name":"relative_price","value":2}],"text":{"en":"All is well, everyone is happy"},"order":{"illness":{"id":99,"name":{"en":"Sarcoma"}}},"clinic_info":{"id":436,"name":"Fuda Cancer Hospital","alias":"fuda-hospital","flags":[{"name":"is_hide","value":false},{"name":"has_active_agencies","value":true}]},"created_at":"2020-01-24T06:26:03.000+00:00","flags":[{"name":"is_approved","value":true},{"name":"is_anonymously","value":true},{"name":"is_notification_sent","value":true},{"name":"would_recommend","value":true},{"name":"has_client_feedback","value":true},{"name":"deactivated_clinic","value":false}]},{"id":6220,"user":{"id":148762,"name":"Myram ","country_code":"HK"},"ratings":[{"name":"main","value":3},{"name":"comfort","value":3},{"name":"coordination","value":3},{"name":"doctor","value":2},{"name":"manager","value":3},{"name":"personal","value":0},{"name":"translation","value":4},{"name":"relative_price","value":0}],"text":{"en":"The coordinator was helpful and provide the information as far as possible.  The hospital arranged a native Cantonese speaker who acted as a translator.  This arrangement facilitated the communication.     The consultation was abit rush as the doctor had other engagement and needed to leave for urgent duties.  On the treatment aspect,  hope to have more explanation and medical advice.  \n\nOn request,   the coordinator brought us to visit the wards and private rooms and that helped me to understand the environment if I choose to treat in Fuda hospital."},"order":{},"clinic_info":{"id":436,"name":"Fuda Cancer Hospital","alias":"fuda-hospital","flags":[{"name":"is_hide","value":false},{"name":"has_active_agencies","value":true}]},"created_at":"2019-12-24T10:03:35.000+00:00","flags":[{"name":"is_approved","value":true},{"name":"is_anonymously","value":false},{"name":"is_notification_sent","value":true},{"name":"would_recommend","value":false},{"name":"has_client_feedback","value":true},{"name":"deactivated_clinic","value":false}]}],"meta":{"total_count":20,"total_pages":1}},"offers":{"cards":[{"image_count":0,"images":[],"offer":{"id":"6a7c30b9d34db297d9083bb5","name":"Immunotherapy Program with PD-1 Inhibitor","type":"procedure","is_advertising":true,"tags":[],"for_who":"<ul>\n<li>Liao Zhengyin is a chief physician and top-tier expert at West China Hospital Cancer Center, specializing in complex tumor multidisciplinary care.</li>\n<li>uni-asia hospital treats 20,000 patients annually, including children and adults from Arab League, Asia, and Russian-speaking countries.</li>\n<li><strong>Included Services:</strong> 24-hour nurse services.</li>\n<li><strong>Stay Info:</strong> Accommodation and transfer are not included; 0 days stay in the hospital or hotel.</li>\n<li><strong>Method:</strong> Immunotherapy program (PD-1 inhibitor).</li>\n</ul>","clinic_entity_text":"<p>Uni-Asia Cancer Hospital treats 20,000+ patients every year using a multidisciplinary approach. The medical team specializes in combining immune checkpoint inhibitors with local therapies like NanoKnife or cryoablation for refractory tumors. Treatment plans are personalized based on PD-L1 expression testing to improve precision. Dr. Luo Jiamin leads these complex strategies, focusing on advanced lung and liver cancers. The facility offers 80 hotel-standard private rooms and full-course management from the first consultation through follow-up care.</p>","package_price":3000,"actual_price":2000,"calculated_price":{"from":0,"to":0},"special_price":{"expires":"2026-12-30T00:00:00.000+00:00","price_usd":2000},"currency":{"code":"USD","symbol":"$","name":"Доллар","rate":1},"doctors":[{"id":13907,"name":"Liao Zhengyin","alias":"liao-zhengyin","photo":"doctor/6a697a03af34c","first_year_working":1991,"short_description":"<p>Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.</p>\n<p>Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.</p>\n<p>Leads 2 provincial S&amp;T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.</p>","specialities":[{"id":"onc.001","name":"Clinical oncologist","illness_kind_id":10},{"id":"onc.002","name":"Gynecologic oncologist","illness_kind_id":10},{"id":"onc.003","name":"Orthopedic oncologist","illness_kind_id":10}],"statistics":{"operations_performed_count":100000}}],"clinic":{"id":8327,"alias":"uni-asia-hospital","name":"Uni-asia Cancer hospital","short_description":"<p>Uni-asia Cancer Hospital is a private single-specialty medical center located in Chengdu, China, dedicated to oncology, including interventional therapy for liver cancer. A patient with liver cancer achieved complete recovery following interventional therapy at the hospital, an exceptionally rare outcome documented in the medical records.</p><p>Uni-asia Cancer Hospital serves adults only and treats 20,000 patients every year, with patients coming most often from Arab League states, Europe, and the United States.</p>","images":[{"base_url":"clinic/6a6964fa14866","title":"Clinic facade of Uni-Asia Cancer Hospital with modern exterior and landscaped greenery"}],"flags":[{"name":"has_active_agencies","value":true},{"name":"is_hide","value":false}],"geo":{"country":{"name":"China","id":203,"alias":"china","iso_code":"CN"},"city":{"name":"Chengdu","id":2693,"alias":"chengdu"},"address":"China, Si Chuan Sheng, Cheng Du Shi, Cheng Hua Qu, Huai Shu Dian Lu, 40-268号成都汇康中西医结合医院 邮政编码: 610058"},"rating":{"rating":0,"google":4.5,"percent_of_satisfied_clients":0},"statistics":{"number_of_reviews":0},"accreditations":[]}}}],"metadata":{"total_count":1}},"promoOffers":[{"image_count":0,"images":[],"offer":{"id":"6a7c30b9d34db297d9083bb5","name":"Immunotherapy Program with PD-1 Inhibitor","type":"procedure","is_advertising":true,"tags":[],"for_who":"<ul>\n<li>Liao Zhengyin is a chief physician and top-tier expert at West China Hospital Cancer Center, specializing in complex tumor multidisciplinary care.</li>\n<li>uni-asia hospital treats 20,000 patients annually, including children and adults from Arab League, Asia, and Russian-speaking countries.</li>\n<li><strong>Included Services:</strong> 24-hour nurse services.</li>\n<li><strong>Stay Info:</strong> Accommodation and transfer are not included; 0 days stay in the hospital or hotel.</li>\n<li><strong>Method:</strong> Immunotherapy program (PD-1 inhibitor).</li>\n</ul>","clinic_entity_text":"<p>Uni-Asia Cancer Hospital treats 20,000+ patients every year using a multidisciplinary approach. The medical team specializes in combining immune checkpoint inhibitors with local therapies like NanoKnife or cryoablation for refractory tumors. Treatment plans are personalized based on PD-L1 expression testing to improve precision. Dr. Luo Jiamin leads these complex strategies, focusing on advanced lung and liver cancers. The facility offers 80 hotel-standard private rooms and full-course management from the first consultation through follow-up care.</p>","package_price":3000,"actual_price":2000,"calculated_price":{"from":0,"to":0},"special_price":{"expires":"2026-12-30T00:00:00.000+00:00","price_usd":2000},"currency":{"code":"USD","symbol":"$","name":"Доллар","rate":1},"doctors":[{"id":13907,"name":"Liao Zhengyin","alias":"liao-zhengyin","photo":"doctor/6a697a03af34c","first_year_working":1991,"short_description":"<p>Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.</p>\n<p>Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.</p>\n<p>Leads 2 provincial S&amp;T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.</p>","specialities":[{"id":"onc.001","name":"Clinical oncologist","illness_kind_id":10},{"id":"onc.002","name":"Gynecologic oncologist","illness_kind_id":10},{"id":"onc.003","name":"Orthopedic oncologist","illness_kind_id":10}],"statistics":{"operations_performed_count":100000}}],"clinic":{"id":8327,"alias":"uni-asia-hospital","name":"Uni-asia Cancer hospital","short_description":"<p>Uni-asia Cancer Hospital is a private single-specialty medical center located in Chengdu, China, dedicated to oncology, including interventional therapy for liver cancer. A patient with liver cancer achieved complete recovery following interventional therapy at the hospital, an exceptionally rare outcome documented in the medical records.</p><p>Uni-asia Cancer Hospital serves adults only and treats 20,000 patients every year, with patients coming most often from Arab League states, Europe, and the United States.</p>","images":[{"base_url":"clinic/6a6964fa14866","title":"Clinic facade of Uni-Asia Cancer Hospital with modern exterior and landscaped greenery"}],"flags":[{"name":"has_active_agencies","value":true},{"name":"is_hide","value":false}],"geo":{"country":{"name":"China","id":203,"alias":"china","iso_code":"CN"},"city":{"name":"Chengdu","id":2693,"alias":"chengdu"},"address":"China, Si Chuan Sheng, Cheng Du Shi, Cheng Hua Qu, Huai Shu Dian Lu, 40-268号成都汇康中西医结合医院 邮政编码: 610058"},"rating":{"rating":0,"google":4.5,"percent_of_satisfied_clients":0},"statistics":{"number_of_reviews":0},"accreditations":[]}}}],"listingTexts":{"entity_texts":{},"texts":{"guide_mc":{"text":"<p>Day 1</p>\n<ul>\n<li>Arrive in the country and transfer to the hotel.</li>\n<li>Rest and adjust to the new environment.</li>\n</ul>\n\n<p>Day 2</p>\n<ul>\n<li>Transfer to the clinic.</li>\n<li>Consultation with specialists about your medical history and current health condition.</li>\n<li>Perform necessary medical tests like blood tests, allergy tests, etc.</li>\n</ul>\n\n<p>Day 3</p>\n<ul>\n<li>Discussion about the results of your medical tests.</li>\n<li>Plan and schedule your immunotherapy treatment.</li>\n</ul>\n\n<p>Day 4</p>\n<ul>\n<li>Start of your immunotherapy treatment.</li>\n<li>The process lasts for about 2-3 hours without the need for anesthesia.</li>\n<li>Observe your reaction to the treatment under medical supervision.</li>\n</ul>\n\n<p>Day 5 to Day 7</p>\n<ul>\n<li>Continue with your immunotherapy sessions as scheduled.</li>\n<li>Regular monitoring of your condition by the medical team.</li>\n</ul>\n\n<p>Week 2</p>\n<ul>\n<li>Completion of your immunotherapy treatment.</li>\n<li>Post-treatment consultation and guidelines.</li>\n<li>Transfer back to the hotel.</li>\n</ul>\n\n<p>Week 3</p>\n<ul>\n<li>Recovery period at the hotel.</li>\n<li>Gradual return to daily activities.</li>\n</ul>\n\n<p>Week 4</p>\n<ul>\n<li>Check out from the hotel.</li>\n<li>Transfer to the airport for departure.</li>\n</ul>\n\n<p><i>Please note that each patient\"s case is unique and the above schedule can change depending on the patient\"s health condition and response to the treatment.</i></p>"}}},"articles":[{"id":"en:the-cost-of-immunotherapy-for-cancer-a-global-comparison-and-affordable-options","name":"Immunotherapy for Cancer Cost: Global Comparison 2026","image":{"main":"https://bookimed.s3.eu-central-1.amazonaws.com/articles/e6d5_b.jpeg","preview":"https://bookimed.s3.eu-central-1.amazonaws.com/articles/e6d5_s.jpeg"},"author":{"first_name":"Kateryna","last_name":"Zamkovska","avatar":"https://s3.eu-central-1.amazonaws.com/bookimed/admin/66ab3953e4c4e_b.jpeg"}}],"relations":{"countries":[{"name":"Austria","alias":"austria","iso_code":"AT"},{"name":"Azerbaijan","alias":"azerbaijan","iso_code":"AZ"},{"name":"China","alias":"china","iso_code":"CN"},{"name":"Czech Republic","alias":"czech-republic","iso_code":"CZ"},{"name":"Dominican Republic","alias":"dominican-republic","iso_code":"DO"},{"name":"Egypt","alias":"egypt","iso_code":"EG"},{"name":"Germany","alias":"germany","iso_code":"DE"},{"name":"Greece","alias":"greece","iso_code":"GR"},{"name":"India","alias":"india","iso_code":"IN"},{"name":"Israel","alias":"israel","iso_code":"IL"},{"name":"Italy","alias":"italy","iso_code":"IT"},{"name":"Japan","alias":"japan","iso_code":"JP"},{"name":"Latvia","alias":"latvia","iso_code":"LV"},{"name":"Lithuania","alias":"lithuania","iso_code":"LT"},{"name":"Malaysia","alias":"malaysia","iso_code":"MY"},{"name":"Mexico","alias":"mexico","iso_code":"MX"},{"name":"Morocco","alias":"morocco","iso_code":"MA"},{"name":"Republic of Korea","alias":"republic-of-korea","iso_code":"KR"},{"name":"Spain","alias":"spain","iso_code":"ES"},{"name":"Switzerland","alias":"switzerland","iso_code":"CH"},{"name":"Thailand","alias":"thailand","iso_code":"TH"},{"name":"Turkey","alias":"turkey","iso_code":"TR"},{"name":"Ukraine","alias":"ukraine","iso_code":"UA"},{"name":"United Arab Emirates","alias":"united-arab-emirates","iso_code":"AE"},{"name":"United Kingdom","alias":"united-kingdom","iso_code":"GB"},{"name":"United States of America","alias":"united-states","iso_code":"US"}],"cities":[{"name":"Hainan Province","alias":"hainan-province"},{"name":"Chengdu","alias":"chengdu"},{"name":"Qionghai","alias":"qionghai"},{"name":"Shanghai","alias":"shanghai"},{"name":"Beijing","alias":"beijing"},{"name":"Guangzhou","alias":"guangzhou"}],"operations":[{"name":"Immunotherapy","alias":"immunotherapy"},{"name":"Chemotherapy","alias":"chemotherapy"},{"name":"Radiofrequency ablation","alias":"radiofrequency-ablation"},{"name":"Radiotherapy","alias":"radiotherapy"},{"name":"Targeted therapy","alias":"targeted-therapy"},{"name":"High intensity focused ultrasound ablation (HIFU)","alias":"high-intensity-focused-ultrasound-ablation-hifu"},{"name":"HIFU for prostate cancer treatment","alias":"hifu-for-prostate-cancer-treatment"},{"name":"NanoKnife","alias":"nanoknife"},{"name":"Brachytherapy","alias":"brachytherapy"},{"name":"Brachytherapy for prostate cancer","alias":"brachytherapy-for-prostate-cancer"},{"name":"Chemoembolization of the liver","alias":"chemoembolization-of-the-liver"},{"name":"Radiofrequency ablation of the liver","alias":"radiofrequency-ablation-of-the-liver"},{"name":"Radiotherapy for prostate cancer","alias":"radiotherapy-for-prostate-cancer"},{"name":"Chemotherapy for lung cancer","alias":"chemotherapy-for-lung-cancer"},{"name":"Brachytherapy for uterine cancer","alias":"brachytherapy-for-cervical-cancer"},{"name":"Radiotherapy for lung cancer","alias":"radiotherapy-for-lung-cancer"},{"name":"Cryotherapy for kidney cancer","alias":"cryotherapy-for-kidney-cancer"},{"name":"Brachytherapy for Breast Cancer","alias":"brachytherapy-for-breast-cancer"},{"name":"Chemotherapy for breast cancer","alias":"chemotherapy-for-breast-cancer"},{"name":"Cryotherapy","alias":"cryotherapy"}],"diagnostics":[{"name":"PET/CT","alias":"pet-ct"},{"name":"CT (computer tomography)","alias":"ct"},{"name":"Online Consultation with Oncologist","alias":"online-consultation-with-oncologist"},{"name":"Cancer screening","alias":"screening-for-cancer"},{"name":"CT scan of the whole body","alias":"ct-scan-of-the-whole-body"},{"name":"Tumor Marker Blood Test","alias":"identification-of-tumor-markers"},{"name":"Oncological Check-up for Man","alias":"oncological-check-up-for-man"},{"name":"PET-CT with Gallium 68(PSMA)","alias":"pet-ct-with-gallium-68"}],"illnesses":[{"name":"Breast cancer","alias":"breast-cancer"},{"name":"Prostate cancer","alias":"prostate-cancer"},{"name":"Lung cancer","alias":"lung-cancer"},{"name":"Pancreatic cancer","alias":"pancreatic-cancer"},{"name":"Stomach cancer","alias":"stomach-cancer"},{"name":"Liver cancer","alias":"liver-cancer"},{"name":"Cervical cancer","alias":"cervical-cancer"},{"name":"Colon cancer","alias":"colon-cancer"},{"name":"Sarcoma","alias":"sarcoma"},{"name":"Adenocarcinoma","alias":"adenocarcinoma"},{"name":"Thyroid cancer","alias":"thyroid-cancer"},{"name":"Rectal cancer","alias":"rectal-cancer"},{"name":"Kidney cancer","alias":"kidney-cancer"},{"name":"Glioblastoma","alias":"glioblastoma"},{"name":"Ovarian cancer","alias":"ovarian-cancer"},{"name":"Lung cancer stage 4","alias":"stage-4-lung-cancer"},{"name":"Bladder cancer","alias":"bladder-cancer"},{"name":"Esophageal cancer","alias":"esophageal-cancer"},{"name":"Meningioma","alias":"meningoblastoma"},{"name":"Larynx cancer","alias":"larynx-cancer"},{"name":"Uterine cancer","alias":"cancer-of-the-uterus"},{"name":"Glioma","alias":"glioma"},{"name":"Bone cancer","alias":"bone-cancer"},{"name":"Brain Cancer","alias":"brain-cancer"},{"name":"Metastases in the liver","alias":"metastases-in-the-liver"},{"name":"Testicular cancer","alias":"testicular-cancer"},{"name":"Osteosarcoma","alias":"osteosarcoma"},{"name":"Basalioma","alias":"basalioma"},{"name":"Gallbladder cancer","alias":"gallbladder-cancer"},{"name":"Tongue cancer","alias":"cancer-of-the-tongue"},{"name":"Astrocytoma","alias":"astrocytoma"},{"name":"Liver cancer stage 4","alias":"liver-cancer-stage-4"},{"name":"Nasopharyngeal cancer","alias":"cancer-of-the-nasopharynx"},{"name":"Leiomyosarkoma","alias":"leiomyosarkom"},{"name":"Lymphangioma","alias":"lymphangioma"},{"name":"Adrenal tumor","alias":"adrenal-tumor"},{"name":"Tonsil cancer","alias":"tonsil-cancer"},{"name":"Carcinomatosis","alias":"sarcinomatosis"},{"name":"Desmoid Tumor","alias":"desmoid-tumor"},{"name":"Medulloblastoma","alias":"medulloblastoma"},{"name":"Thymoma","alias":"thymoma"},{"name":"Liver cancer stage 3","alias":"liver-cancer-stage-3"},{"name":"Gastric metaplasia","alias":"gastric-metaplasia"},{"name":"Chordoma","alias":"chordoma"},{"name":"Small intestine cancer","alias":"small-intestine-cancer"},{"name":"Sigmoid adenocarcinoma","alias":"sigmoid-adenocarcinoma"},{"name":"Chondrosarcoma","alias":"chondrosarcoma"},{"name":"Colon cancer stage 4","alias":"colon-cancer-stage-4"},{"name":"Stomach cancer stage 2","alias":"stomach-cancer-stage-2"},{"name":"Pancreatic neuroendocrine tumors","alias":"pancreatic-neuroendocrine-tumors"},{"name":"Liver cancer stage 2","alias":"liver-cancer-stage-2"},{"name":"Immunotherapy","alias":"immunotherapy"},{"name":"Paraganglioma","alias":"paraganglioma"},{"name":"Hemophagocytic lymphohistiocytosis (HLH)","alias":"hemophagocytic-lymphohistiocytosis-hlh"}],"illnessKinds":[{"name":"Oncology","alias":"oncology"}],"illness_kinds":[{"name":"Oncology","alias":"oncology"}]},"popularSearches":[{"name":"Immunotherapy","alias":"immunotherapy","type":"operation","id":283},{"name":"Immunotherapy with Keytruda (Pembolizumab)","alias":"keytruda","type":"operation","id":491},{"name":"Chemotherapy","alias":"chemotherapy","type":"operation","id":37},{"name":"Bone marrow transplantation","alias":"bone-marrow-transplantation","type":"operation","id":141},{"name":"Radiofrequency ablation","alias":"radiofrequency-ablation","type":"operation","id":116},{"name":"MRI of one area","alias":"mri-one-department","type":"diagnostic","id":6},{"name":"Colonoscopy","alias":"colonoscopy","type":"diagnostic","id":9},{"name":"PET/CT","alias":"pet-ct","type":"diagnostic","id":1},{"name":"Consultation with an oncologist","alias":"consultation-of-oncologist","type":"diagnostic","id":102},{"name":"Consultation with creation of treatment plan","alias":"consultation-with-creation-of-treatment-plan","type":"diagnostic","id":457},{"name":"Breast cancer","alias":"breast-cancer","type":"illness","id":3},{"name":"Prostate cancer","alias":"prostate-cancer","type":"illness","id":97},{"name":"Lung cancer","alias":"lung-cancer","type":"illness","id":4},{"name":"Pancreatic cancer","alias":"pancreatic-cancer","type":"illness","id":7},{"name":"Stomach cancer","alias":"stomach-cancer","type":"illness","id":51}],"operationPrices":{"operation_prices":{"154":{"operation":{"name":"Biological therapy","alias":"biological-therapy","use_for_listing":true},"country_price":{"US":{"amount":18000,"max_amount":38000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TR":{"amount":2500,"max_amount":6500,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TH":{"amount":6500,"max_amount":12500,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"AT":{"amount":7500,"max_amount":15000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"ES":{"amount":900,"max_amount":7000,"currency":"USD","clinic_count":1,"price_kind":"from_range","price_source":"tariff","scope":"country"},"CN":{"amount":6000,"max_amount":17000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"}},"available_clinics":{"US":false,"TR":false,"TH":false,"AT":false,"ES":true,"CN":false},"description":"<p>This therapy uses living organisms to treat disease by stimulating the body\"s own immune system.</p>"},"283":{"operation":{"name":"Immunotherapy","alias":"immunotherapy","use_for_listing":true},"country_price":{"US":{"amount":15000,"max_amount":42000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TR":{"amount":2500,"max_amount":3500,"currency":"USD","clinic_count":7,"price_kind":"from_range","price_source":"tariff","scope":"country"},"TH":{"amount":5900,"max_amount":13000,"currency":"USD","clinic_count":1,"price_kind":"from_range","price_source":"tariff","scope":"country"},"AT":{"amount":9000,"max_amount":19000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"ES":{"amount":3500,"max_amount":18000,"currency":"USD","clinic_count":2,"price_kind":"from_range","price_source":"tariff","scope":"country"},"CN":{"amount":3000,"max_amount":14000,"currency":"USD","clinic_count":3,"price_kind":"from_range","price_source":"mixed","scope":"country"}},"available_clinics":{"UA":false,"FR":false,"GB":false,"US":false,"IL":true,"TR":true,"MX":false,"DE":false,"CA":false,"AE":false,"TH":true,"PL":false,"KR":false,"CZ":false,"AT":false,"ES":true,"IT":false,"CN":true,"AU":false,"IN":false,"MY":false,"VN":false,"BR":false,"EG":true},"description":"<p>This therapy boosts the body\"s natural defenses to fight diseases like cancer, bringing less side effects.</p>"},"393":{"operation":{"name":"Bacillus Calmette-Guérin (BCG) therapy","alias":"bcz-terapia","use_for_listing":true},"country_price":{"US":{"amount":7000,"max_amount":13500,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TR":{"amount":7000,"max_amount":0,"currency":"USD","clinic_count":1,"price_kind":"from","price_source":"tariff","scope":"country"},"TH":{"amount":1500,"max_amount":2600,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"AT":{"amount":2800,"max_amount":5200,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"ES":{"amount":2600,"max_amount":4300,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"CN":{"amount":1800,"max_amount":3500,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"}},"available_clinics":{"US":false,"TR":true,"TH":false,"AT":false,"ES":false,"CN":false},"description":"<p>This therapy, employing a TB vaccine, aids in bladder cancer treatment, through direct insertion into the bladder.</p>"},"491":{"operation":{"name":"Immunotherapy with Keytruda (Pembolizumab)","alias":"keytruda","use_for_listing":true},"country_price":{"US":{"amount":13500,"max_amount":22000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TR":{"amount":2800,"max_amount":7000,"currency":"USD","clinic_count":8,"price_kind":"from_range","price_source":"tariff","scope":"country"},"TH":{"amount":3600,"max_amount":4600,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"AT":{"amount":5800,"max_amount":8400,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"ES":{"amount":13500,"max_amount":0,"currency":"USD","clinic_count":1,"price_kind":"from","price_source":"offer","scope":"country"},"CN":{"amount":4500,"max_amount":7200,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"}},"available_clinics":{"US":false,"TR":true,"TH":false,"AT":false,"ES":true,"CN":false},"description":"<p>The therapy is a treatment enhancing the body\"s immune system to fight cancer, using a drug highly targeted and effective.</p>"},"696":{"operation":{"name":"Immunotherapy for prostate cancer","alias":"immunotherapy-for-prostate-cancer","use_for_listing":true},"country_price":{"US":{"amount":48000,"max_amount":105000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TR":{"amount":8000,"max_amount":24000,"currency":"USD","clinic_count":1,"price_kind":"from_range","price_source":"tariff","scope":"country"},"TH":{"amount":5900,"max_amount":25000,"currency":"USD","clinic_count":1,"price_kind":"from_range","price_source":"tariff","scope":"country"},"AT":{"amount":9500,"max_amount":20000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"ES":{"amount":6000,"max_amount":18000,"currency":"USD","clinic_count":1,"price_kind":"from_range","price_source":"tariff","scope":"country"},"CN":{"amount":9000,"max_amount":24000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"}},"available_clinics":{"US":false,"TR":true,"TH":true,"AT":false,"ES":true,"CN":false},"description":"<p>This therapy boosts the body\"s immune system to fight against prostate cancer, offering a targeted, typically well-tolerated treatment.</p>"},"712":{"operation":{"name":"Immunotherapy for lung cancer","alias":"immunotherapy-for-lung-cancer","use_for_listing":true},"country_price":{"US":{"amount":11500,"max_amount":22000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TR":{"amount":8000,"max_amount":13000,"currency":"USD","clinic_count":1,"price_kind":"from_range","price_source":"tariff","scope":"country"},"TH":{"amount":5900,"max_amount":42000,"currency":"USD","clinic_count":1,"price_kind":"from_range","price_source":"tariff","scope":"country"},"AT":{"amount":5800,"max_amount":10000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"ES":{"amount":5000,"max_amount":17500,"currency":"USD","clinic_count":1,"price_kind":"from_range","price_source":"tariff","scope":"country"},"CN":{"amount":9500,"max_amount":20000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"}},"available_clinics":{"US":false,"TR":true,"TH":true,"AT":false,"ES":true,"CN":false},"description":"<p>This therapy boosts your body\"s natural defenses to fight lung cancer, using substances made by the body itself.</p>"},"713":{"operation":{"name":"Immunotherapy for breast cancer","alias":"immunotherapy-for-breast-cancer","use_for_listing":true},"country_price":{"US":{"amount":60000,"max_amount":150000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TR":{"amount":8000,"max_amount":16000,"currency":"USD","clinic_count":1,"price_kind":"from_range","price_source":"tariff","scope":"country"},"TH":{"amount":5900,"max_amount":14000,"currency":"USD","clinic_count":1,"price_kind":"from_range","price_source":"tariff","scope":"country"},"AT":{"amount":18000,"max_amount":36000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"ES":{"amount":2200,"max_amount":28000,"currency":"USD","clinic_count":1,"price_kind":"from_range","price_source":"tariff","scope":"country"},"CN":{"amount":14000,"max_amount":36000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"}},"available_clinics":{"US":false,"TR":true,"TH":true,"AT":false,"ES":true,"CN":false},"description":"<p>This therapy boosts your immune system to fight and eradicate breast cancer cells effectively.</p>"},"714":{"operation":{"name":"Immunotherapy for kidney cancer","alias":"immunotherapy-for-kidney-cancer","use_for_listing":true},"country_price":{"US":{"amount":60000,"max_amount":160000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TR":{"amount":8000,"max_amount":25000,"currency":"USD","clinic_count":1,"price_kind":"from_range","price_source":"tariff","scope":"country"},"TH":{"amount":5900,"max_amount":32000,"currency":"USD","clinic_count":1,"price_kind":"from_range","price_source":"tariff","scope":"country"},"AT":{"amount":28000,"max_amount":48000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"ES":{"amount":2200,"max_amount":18000,"currency":"USD","clinic_count":1,"price_kind":"from_range","price_source":"tariff","scope":"country"},"CN":{"amount":9000,"max_amount":22000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"}},"available_clinics":{"US":false,"TR":true,"TH":true,"AT":false,"ES":true,"CN":false},"description":"<p>This therapy boosts the body\"s natural defenses, often prolonging life in kidney cancer patients.</p>"},"831":{"operation":{"name":"Sarcoma Immunotherapy","alias":"sarcoma-immunotherapy","use_for_listing":true},"country_price":{"US":{"amount":60000,"max_amount":140000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TR":{"amount":8900,"max_amount":25000,"currency":"USD","clinic_count":1,"price_kind":"from_range","price_source":"tariff","scope":"country"},"TH":{"amount":14000,"max_amount":23000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"AT":{"amount":18000,"max_amount":40000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"ES":{"amount":6000,"max_amount":28000,"currency":"USD","clinic_count":1,"price_kind":"from_range","price_source":"tariff","scope":"country"},"CN":{"amount":15000,"max_amount":42000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"}},"available_clinics":{"US":false,"TR":true,"TH":false,"AT":false,"ES":true,"CN":false},"description":"<p>This therapy boosts the body\"s immune system to fight cancerous tumors, offering promising, targeted treatment for sarcoma.</p>"}}},"cityPrices":{"operation_prices":{"154":{"operation":{"id":154,"name":"Biological therapy","alias":"biological-therapy"},"city_price":[{"amount":4500,"max_amount":11000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"city","city":{"id":2015,"name":"Shanghai","alias":"shanghai","profile":{"city_id":2015,"city_type":"Most populous city in China","access":["Pudong Airport (PVG), 30 km from the city center","Hongqiao Airport (SHA), 13 km from downtown"],"sources":["https://en.wikipedia.org/wiki/Shanghai","https://en.wikipedia.org/wiki/Shanghai_Pudong_International_Airport","https://en.wikipedia.org/wiki/Shanghai_Hongqiao_International_Airport"],"status":"ok","checked_at":"2026-11-03"}}}]},"283":{"operation":{"id":283,"name":"Immunotherapy","alias":"immunotherapy"},"city_price":[{"amount":3000,"max_amount":0,"currency":"USD","clinic_count":1,"price_kind":"from","price_source":"tariff","scope":"city","city":{"id":2693,"name":"Chengdu","alias":"chengdu","profile":{"city_id":2693,"city_type":"Capital city of Sichuan province, China","access":["Shuangliu Airport (CTU), 16 km from downtown","Tianfu Airport (TFU), 51 km from downtown"],"sources":["https://en.wikipedia.org/wiki/Chengdu","https://en.wikipedia.org/wiki/Chengdu_Shuangliu_International_Airport","https://en.wikipedia.org/wiki/Chengdu_Tianfu_International_Airport"],"status":"ok","checked_at":"2026-11-03"}}},{"amount":4000,"max_amount":0,"currency":"USD","clinic_count":1,"price_kind":"from","price_source":"tariff","scope":"city","city":{"id":390,"name":"Guangzhou","alias":"guangzhou","profile":{"city_id":390,"city_type":"Capital of Guangdong, southern China","access":["Guangzhou Baiyun Airport (CAN), 28 km north of downtown"],"sources":["https://en.wikipedia.org/wiki/Guangzhou","https://en.wikipedia.org/wiki/Guangzhou_Baiyun_International_Airport"],"status":"ok","checked_at":"2026-11-03"}}},{"amount":339000,"max_amount":0,"currency":"USD","clinic_count":1,"price_kind":"from","price_source":"offer","scope":"city","city":{"id":2015,"name":"Shanghai","alias":"shanghai","profile":{"city_id":2015,"city_type":"Most populous city in China","access":["Pudong Airport (PVG), 30 km from the city center","Hongqiao Airport (SHA), 13 km from downtown"],"sources":["https://en.wikipedia.org/wiki/Shanghai","https://en.wikipedia.org/wiki/Shanghai_Pudong_International_Airport","https://en.wikipedia.org/wiki/Shanghai_Hongqiao_International_Airport"],"status":"ok","checked_at":"2026-11-03"}}},{"amount":4200,"max_amount":11500,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"city","city":{"id":360,"name":"Beijing","alias":"beijing","profile":{"city_id":360,"city_type":"Capital city of China","access":["Beijing Capital Airport (PEK), 32 km from downtown"],"sources":["https://en.wikipedia.org/wiki/Beijing","https://en.wikipedia.org/wiki/Beijing_Capital_International_Airport"],"status":"ok","checked_at":"2026-11-03"}}}]},"393":{"operation":{"id":393,"name":"Bacillus Calmette-Guérin (BCG) therapy","alias":"bcz-terapia"},"city_price":[{"amount":1800,"max_amount":3500,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"city","city":{"id":2015,"name":"Shanghai","alias":"shanghai","profile":{"city_id":2015,"city_type":"Most populous city in China","access":["Pudong Airport (PVG), 30 km from the city center","Hongqiao Airport (SHA), 13 km from downtown"],"sources":["https://en.wikipedia.org/wiki/Shanghai","https://en.wikipedia.org/wiki/Shanghai_Pudong_International_Airport","https://en.wikipedia.org/wiki/Shanghai_Hongqiao_International_Airport"],"status":"ok","checked_at":"2026-11-03"}}}]},"491":{"operation":{"id":491,"name":"Immunotherapy with Keytruda (Pembolizumab)","alias":"keytruda"},"city_price":[{"amount":4000,"max_amount":6800,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"city","city":{"id":390,"name":"Guangzhou","alias":"guangzhou","profile":{"city_id":390,"city_type":"Capital of Guangdong, southern China","access":["Guangzhou Baiyun Airport (CAN), 28 km north of downtown"],"sources":["https://en.wikipedia.org/wiki/Guangzhou","https://en.wikipedia.org/wiki/Guangzhou_Baiyun_International_Airport"],"status":"ok","checked_at":"2026-11-03"}}},{"amount":4100,"max_amount":5600,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"city","city":{"id":2015,"name":"Shanghai","alias":"shanghai","profile":{"city_id":2015,"city_type":"Most populous city in China","access":["Pudong Airport (PVG), 30 km from the city center","Hongqiao Airport (SHA), 13 km from downtown"],"sources":["https://en.wikipedia.org/wiki/Shanghai","https://en.wikipedia.org/wiki/Shanghai_Pudong_International_Airport","https://en.wikipedia.org/wiki/Shanghai_Hongqiao_International_Airport"],"status":"ok","checked_at":"2026-11-03"}}}]},"696":{"operation":{"id":696,"name":"Immunotherapy for prostate cancer","alias":"immunotherapy-for-prostate-cancer"},"city_price":[{"amount":12800,"max_amount":34000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"city","city":{"id":390,"name":"Guangzhou","alias":"guangzhou","profile":{"city_id":390,"city_type":"Capital of Guangdong, southern China","access":["Guangzhou Baiyun Airport (CAN), 28 km north of downtown"],"sources":["https://en.wikipedia.org/wiki/Guangzhou","https://en.wikipedia.org/wiki/Guangzhou_Baiyun_International_Airport"],"status":"ok","checked_at":"2026-11-03"}}},{"amount":9000,"max_amount":20000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"city","city":{"id":2015,"name":"Shanghai","alias":"shanghai","profile":{"city_id":2015,"city_type":"Most populous city in China","access":["Pudong Airport (PVG), 30 km from the city center","Hongqiao Airport (SHA), 13 km from downtown"],"sources":["https://en.wikipedia.org/wiki/Shanghai","https://en.wikipedia.org/wiki/Shanghai_Pudong_International_Airport","https://en.wikipedia.org/wiki/Shanghai_Hongqiao_International_Airport"],"status":"ok","checked_at":"2026-11-03"}}}]},"712":{"operation":{"id":712,"name":"Immunotherapy for lung cancer","alias":"immunotherapy-for-lung-cancer"},"city_price":[{"amount":3500,"max_amount":8500,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"city","city":{"id":390,"name":"Guangzhou","alias":"guangzhou","profile":{"city_id":390,"city_type":"Capital of Guangdong, southern China","access":["Guangzhou Baiyun Airport (CAN), 28 km north of downtown"],"sources":["https://en.wikipedia.org/wiki/Guangzhou","https://en.wikipedia.org/wiki/Guangzhou_Baiyun_International_Airport"],"status":"ok","checked_at":"2026-11-03"}}},{"amount":6500,"max_amount":13000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"city","city":{"id":2015,"name":"Shanghai","alias":"shanghai","profile":{"city_id":2015,"city_type":"Most populous city in China","access":["Pudong Airport (PVG), 30 km from the city center","Hongqiao Airport (SHA), 13 km from downtown"],"sources":["https://en.wikipedia.org/wiki/Shanghai","https://en.wikipedia.org/wiki/Shanghai_Pudong_International_Airport","https://en.wikipedia.org/wiki/Shanghai_Hongqiao_International_Airport"],"status":"ok","checked_at":"2026-11-03"}}}]},"713":{"operation":{"id":713,"name":"Immunotherapy for breast cancer","alias":"immunotherapy-for-breast-cancer"},"city_price":[{"amount":6800,"max_amount":16200,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"city","city":{"id":390,"name":"Guangzhou","alias":"guangzhou","profile":{"city_id":390,"city_type":"Capital of Guangdong, southern China","access":["Guangzhou Baiyun Airport (CAN), 28 km north of downtown"],"sources":["https://en.wikipedia.org/wiki/Guangzhou","https://en.wikipedia.org/wiki/Guangzhou_Baiyun_International_Airport"],"status":"ok","checked_at":"2026-11-03"}}},{"amount":9000,"max_amount":20000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"city","city":{"id":2015,"name":"Shanghai","alias":"shanghai","profile":{"city_id":2015,"city_type":"Most populous city in China","access":["Pudong Airport (PVG), 30 km from the city center","Hongqiao Airport (SHA), 13 km from downtown"],"sources":["https://en.wikipedia.org/wiki/Shanghai","https://en.wikipedia.org/wiki/Shanghai_Pudong_International_Airport","https://en.wikipedia.org/wiki/Shanghai_Hongqiao_International_Airport"],"status":"ok","checked_at":"2026-11-03"}}}]},"714":{"operation":{"id":714,"name":"Immunotherapy for kidney cancer","alias":"immunotherapy-for-kidney-cancer"},"city_price":[{"amount":3500,"max_amount":9800,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"city","city":{"id":390,"name":"Guangzhou","alias":"guangzhou","profile":{"city_id":390,"city_type":"Capital of Guangdong, southern China","access":["Guangzhou Baiyun Airport (CAN), 28 km north of downtown"],"sources":["https://en.wikipedia.org/wiki/Guangzhou","https://en.wikipedia.org/wiki/Guangzhou_Baiyun_International_Airport"],"status":"ok","checked_at":"2026-11-03"}}},{"amount":14000,"max_amount":32000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"city","city":{"id":2015,"name":"Shanghai","alias":"shanghai","profile":{"city_id":2015,"city_type":"Most populous city in China","access":["Pudong Airport (PVG), 30 km from the city center","Hongqiao Airport (SHA), 13 km from downtown"],"sources":["https://en.wikipedia.org/wiki/Shanghai","https://en.wikipedia.org/wiki/Shanghai_Pudong_International_Airport","https://en.wikipedia.org/wiki/Shanghai_Hongqiao_International_Airport"],"status":"ok","checked_at":"2026-11-03"}}}]},"831":{"operation":{"id":831,"name":"Sarcoma Immunotherapy","alias":"sarcoma-immunotherapy"},"city_price":[{"amount":18000,"max_amount":36000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"city","city":{"id":2015,"name":"Shanghai","alias":"shanghai","profile":{"city_id":2015,"city_type":"Most populous city in China","access":["Pudong Airport (PVG), 30 km from the city center","Hongqiao Airport (SHA), 13 km from downtown"],"sources":["https://en.wikipedia.org/wiki/Shanghai","https://en.wikipedia.org/wiki/Shanghai_Pudong_International_Airport","https://en.wikipedia.org/wiki/Shanghai_Hongqiao_International_Airport"],"status":"ok","checked_at":"2026-11-03"}}}]}}},"videoReviews":[{"id":"b8c75ace-4f1f-46d8-9887-d9e0b74bfdb6","link":"https://player.vimeo.com/video/1096293607?badge=0&amp;autopause=0&amp;player_id=0&amp;app_id=58479","description":"My companion and I were treated with such kindness — I have nothing but admiration for the entire team.","userName":"Amanda","user_name":"Amanda","preview":"https://i.vimeocdn.com/video/2030326588-92c5121ee6fb5bedb09b0cf12abe66667acab73d0dea713b5168e6353daa6b76-d?mw=600&mh=1067&q=70","updated_at":"2025-06-26T10:47:55.613+00:00","clinicName":"Lokman Hekim Istanbul Hospital","clinic":{"name":"Lokman Hekim Istanbul Hospital","alias":"lokman-hekim-istanbul"},"clinicUrl":"/clinic/lokman-hekim-istanbul/","relations":{"operations":[{"name":"Mastectomy","alias":"mastectomy"},{"name":"Sarcoma surgery","alias":"removal-of-ewing-s-sarcoma"}]}},{"id":"b7a1e6f5-3dff-4271-a473-718866134d6d","link":"https://player.vimeo.com/video/1096286146?badge=0&amp;autopause=0&amp;player_id=0&amp;app_id=58479","description":"Stay strong, stay informed, and never underestimate the power of cutting-edge treatments and a solid support system.","userName":"Randolph","user_name":"Randolph","preview":"https://i.vimeocdn.com/video/2030316574-2e75554b099788479c44c329a4e0921804438f5ec01b95cf5caf584c386aeb01-d?mw=600&mh=1067&q=70","updated_at":"2025-06-26T11:53:30.932+00:00","clinicName":"Confraternitaet & Goldenes Kreuz Private Clinic","clinic":{"name":"Confraternitaet & Goldenes Kreuz Private Clinic","alias":"private-clinic-confraternitat-josefstadt"},"clinicUrl":"/clinic/private-clinic-confraternitat-josefstadt/","relations":{"operations":[{"name":"Radioembolization for liver cancer","alias":"radioembolization-for-liver-cancer"},{"name":"Radiofrequency ablation","alias":"radiofrequency-ablation"}]}}],"hasVideoReviewsByContext":true,"externalReviews":[{"id":"6ae603c792e955ae2b04259d","source":"google","clinic_id":8327},{"id":"6ae603dca694e0e3d10bea69","source":"google","clinic_id":8327},{"id":"6ae603dec48fbcf1a00fd1a8","source":"google","clinic_id":8327},{"id":"6ae603e392e955ae2b04259e","source":"google","clinic_id":8327},{"id":"6ae603e4a694e0e3d10bea6a","source":"google","clinic_id":8327}],"responsibleDoctor":{"id":290,"alias":"yesim-yildirim","name":"Yesim Yildirim","photo":"doctor/699da18e34fa6","advisory_text":"20 years of experience\nMedical oncologist, ESMO certified","advisoryText":"20 years of experience\nMedical oncologist, ESMO certified","specialities":[{"id":"onc.001","name":"Clinical oncologist","illness_kind_id":10}]},"updatedAt":"2026-11-21T00:00:13.677Z","activeCountries":["CN","TR","AT","ES","TH"],"operationIndicators":{"details":{"anesthesia":"local","days_in_clinic":1,"days_in_country":3,"rehabilitation_days":1,"satisfied_percent":78,"treatment_duration_hours":2},"illness_kind_details":{"requests_processed":46119}},"direction":{"id":10,"name":"Oncology","alias":"oncology","name_forms":{"base_form":"Oncology","form_4":"oncologist","form_6":"oncologists","form_11":"oncologists"}},"illness_kind":{"id":10,"name":{"en":"Oncology"}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["none"],"back_to_work_days":{"min":1,"max":3,"unit":"days","qualifier":"Fatigue after each infusion and any immune-related side effects determine return to work."},"complication_rate_pct":{"min":60,"max":80,"unit":"percent","qualifier":"Any immune-related adverse event on single-agent checkpoint inhibitor; grade 3-4 events about 10-20%."},"contraindications":["Active severe autoimmune disease requiring immunosuppression","Organ transplant recipient","Pregnancy or breastfeeding","Previous severe immune-related reaction to the same drug","Active uncontrolled infection","Chronic systemic steroid therapy above low dose","Hypersensitivity to the drug or its components"],"days_in_clinic":{"min":0,"max":0,"unit":"nights","qualifier":"Infusion is given in a treatment chair and the patient goes home the same day."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":0,"max":1,"unit":"weeks","qualifier":"Light activity is possible the next day; intensity depends on fatigue and side effects."},"final_result_months":{"min":3,"max":6,"unit":"months","qualifier":"Response is judged on imaging after several cycles; responses can be delayed."},"fly_home_after_days":{"min":0,"max":1,"unit":"days","qualifier":"Same or next day after the first infusion if no reaction; later cycles at home."},"follow_up_visits":[{"purpose":"assessment","after":{"min":14,"max":42,"unit":"days","qualifier":"Blood tests and symptom review before each next cycle."},"requirement":"routine"},{"purpose":"result_review","after":{"min":60,"max":90,"unit":"days","qualifier":"First response imaging after about 3-4 cycles."},"requirement":"routine"},{"purpose":"other","after":{"min":7,"max":365,"unit":"days","qualifier":"Visit for suspected immune-related side effects, any time during or after treatment."},"requirement":"conditional"}],"indications":["Melanoma","Non-small cell lung cancer","Renal cell carcinoma","Bladder and urothelial cancer","Head and neck squamous cell cancer","Hodgkin lymphoma","Tumors with high microsatellite instability or mutational burden","Hepatocellular carcinoma"],"main_risks":["Fatigue and rash","Immune colitis and diarrhea","Pneumonitis","Hepatitis","Thyroid and other endocrine disorders","Infusion reactions","Rare myocarditis or neurological inflammation"],"pain":"Minimal; only a needle insertion for the intravenous infusion. Mild aches or headache may follow.","preparation":["Confirm diagnosis and biomarker testing (e.g., PD-L1)","Blood tests including liver, kidney and thyroid","Screen for hepatitis, HIV and tuberculosis","Review autoimmune history and current medications","Baseline imaging","Review of steroid and antibiotic use"],"recovery_timeline":[{"phase":"Infusion day","description":"Intravenous infusion lasting 30-60 minutes with observation, then home.","restrictions":["Report fever, breathlessness or rash"]},{"phase":"Days 1-3","description":"Possible mild fatigue, low fever or aches.","restrictions":["Avoid strenuous exertion if tired"]},{"phase":"Weeks 1-6","description":"Window when immune-related side effects such as diarrhea, rash or cough may appear.","restrictions":["Report new symptoms promptly","Do not self-treat diarrhea"]},{"phase":"Ongoing cycles","description":"Repeated infusions every 2-6 weeks with monitoring and periodic imaging.","restrictions":["Avoid live vaccines unless approved by the oncologist"]}],"rehabilitation_days":{"min":1,"max":3,"unit":"days","qualifier":"Time to normal function after each infusion; depends on fatigue and side effects."},"result_longevity":"Responders may keep durable control for years, while others progress within months. Duration depends on cancer type and response depth.","revision_rate_pct":{"min":10,"max":20,"unit":"percent","qualifier":"Share of patients stopping therapy for immune-related toxicity; varies by drug and tumor."},"scars":"No scars; treatment is an IV infusion without incisions.","sessions_or_stages":{"sessions":{"min":4,"max":35,"unit":"visits","qualifier":"Infusions every 2-6 weeks; length depends on drug, response and tolerance, up to about two years."},"stages":[{"code":"baseline_workup","label":"Baseline testing and imaging","after":{"min":0,"max":0,"unit":"days","qualifier":"Before the first infusion."}},{"code":"first_infusion","label":"First infusion cycle","after":{"min":0,"max":0,"unit":"days","qualifier":"Start of treatment."}},{"code":"maintenance_cycles","label":"Repeat cycles with monitoring","after":{"min":14,"max":42,"unit":"days","qualifier":"Interval between cycles depends on the drug."}},{"code":"response_imaging","label":"Response assessment imaging","after":{"min":60,"max":90,"unit":"days","qualifier":"After about 3-4 cycles."}}],"qualifier":"Repeated infusion cycles continue while the cancer responds and side effects are tolerable."},"success":{"metric":"Objective tumor response rate on imaging","value":30,"unit":"percent of patients","horizon":"3-6 months","population":"Adults with advanced melanoma, lung, kidney or bladder cancer on PD-1/PD-L1 inhibitor","evidence_status":"limited"},"techniques":[{"name":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","suits_whom":"Melanoma, lung, kidney and many other solid tumors.","recovery":"Same-day discharge; immune side effects are common and monitored."},{"name":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","suits_whom":"Lung, bladder and liver cancers.","recovery":"Same-day discharge; immune side effects monitored."},{"name":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","suits_whom":"Selected melanoma and kidney cancer patients.","recovery":"Higher side-effect rate; closer monitoring needed."}],"treatment_conditions":["outpatient"],"treatment_duration_hours":{"min":1,"max":3,"unit":"hours","qualifier":"Per visit, including check-in, blood tests, 30-60 minute infusion and observation."},"initial_assessment_documents":["Pathology report confirming cancer diagnosis","Biomarker results such as PD-L1 or MSI","Recent CT or PET imaging reports","Recent blood test results","List of current medications and steroid use","Records of previous cancer treatments"],"travel_trips":{"min":1,"max":6,"one_trip_possible":true,"qualifier":"One trip for the first cycle, then treatment continues at home; 4-6 trips if cycles are given abroad."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Check the qualifications of the clinician who will do the procedure","scope":"treatment_abroad","source":{"url":"https://wwwnc.cdc.gov/travel/page/medical-tourism","host":"wwwnc.cdc.gov","quote":"Check the qualifications of the clinician who will be doing the procedure.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C2","text":"Check the facilities and standards of the clinic or hospital where treatment will be given","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Are you satisfied with the facilities and standards at the clinic or hospital where you'll be treated?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C3","text":"Make sure you understand the possible complications and side effects of the treatment","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Make sure you understand the possible complications and side effects that could arise from your treatment.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C4","text":"Ask whether a doctor is always present in the clinic and whether a high dependency or intensive care unit exists","scope":"treatment_abroad","source":{"url":"https://www.bapras.org.uk/public/patient-information/cosmetic-surgery/cosmetic-surgery-abroad","host":"bapras.org.uk","quote":"Is there always a doctor in the clinic and is there a high dependency or intensive care unit?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C5","text":"Ask for certification information and the name of the body that certified the surgical setting","scope":"treatment_abroad","source":{"url":"https://www.isaps.org/discover/patients-home/considering-your-procedure-abroad/finding-a-surgeon-abroad/","host":"isaps.org","quote":"Ask for certification information and the name of the certifying body when assessing a surgical setting.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2027-11-11","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Patient cannot ask the treating doctor questions about the treatment before it starts","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/using-the-nhs/healthcare-abroad/going-abroad-for-treatment/treatment-abroad-checklist/","host":"nhs.uk","quote":"Have you been able to ask them questions about your treatment?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F2","text":"Consultation or care offered in a language you do not speak fluently risks misunderstandings","scope":"treatment_abroad","source":{"url":"https://wwwnc.cdc.gov/travel/page/medical-tourism","host":"wwwnc.cdc.gov","quote":"Receiving care at a facility where you do not speak the language fluently could lead to misunderstandings about your care.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F3","text":"Pressure to decide quickly, or cheap time-limited offers, is a warning sign","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2027-11-11","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Feeling short of breath","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/organ-inflammation","host":"cancer.gov","quote":"Inflammation in the lungs, called pneumonitis, can cause you to feel short of breath and have a bad cough.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"W2","text":"Painful blisters, open sores, or peeling skin","urgency":"contact_clinic","general":false,"source":{"url":"https://www.mdanderson.org/patients-family/diagnosis-treatment/emotional-physical-effects/immunotherapy-treatment-side-effects.html","host":"mdanderson.org","quote":"Contact your care team if you experience painful blisters, open sores, fever or skin that begins to peel.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"W3","text":"Yellowing of skin or eyes","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/organ-inflammation","host":"cancer.gov","quote":"Liver inflammation, called hepatitis, may cause your skin and eyes to be yellowish.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"W4","text":"Diarrhea","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/diarrhea","host":"cancer.gov","quote":"Tell your doctor or nurse if you are having diarrhea.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2027-11-11","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Keep showing it to treating staff for up to a year after stopping steroids","document":"steroid alert card","source":{"url":"https://www.worcsacute.nhs.uk/leaflets/iocn-immunotherapy-patient-information-leaflet/","host":"worcsacute.nhs.uk","quote":"Always carry this card and show it to anybody that treats you up to one year after stopping steroids.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T2","text":"Home doctor needs the clinic's follow-up recommendations in a written discharge summary","document":"discharge summary","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"When you have treatment abroad, you must ask the treatment provider for their follow-up recommendations documented within a written discharge summary in English.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T3","text":"Ask for copies of all prescriptions before you leave","document":"prescription copies","source":{"url":"https://travelhealthpro.org.uk/news/699/travelling-abroad-for-treatment","host":"travelhealthpro.org.uk","quote":"Remember to ask for copies of all your treatment records, including prescriptions, scans and x-rays before you leave.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"T4","text":"Home doctor needs the dates for required blood tests and follow-up appointments","document":"written aftercare plan","source":{"url":"https://sbuhb.nhs.wales/about-us/individual-patient-commissioning/ipc-folder/advice-on-accessing-treatment-abroad","host":"sbuhb.nhs.wales","quote":"This should include any medication and doses, as well as any dates that blood tests and follow-up appointments must be carried out.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-11","next_check_at":"2027-11-11","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"Your team recommends drugs that kill cancer cells","name":"Chemotherapy","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/chemotherapy","host":"cancer.gov","quote":"Chemotherapy (also called chemo) is a type of cancer treatment that uses drugs to kill cancer cells.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200},"operation_id":37}],"checked_at":"2026-11-11","next_check_at":"2027-11-11","version":1},"technique_details":{"status":"ok","items":[{"id":"pd-1-inhibitor-infusion","name":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","how_it_works":{"text":"Blocks checkpoints so immune cells respond more strongly to cancer","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"By blocking them, these drugs allow immune cells to respond more strongly to cancer.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"pd-l1-inhibitor-infusion","name":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","how_it_works":{"text":"Blocks checkpoints so immune cells respond more strongly to cancer","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy","host":"cancer.gov","quote":"By blocking them, these drugs allow immune cells to respond more strongly to cancer.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"ctla-4-inhibitor-combination","name":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","how_it_works":{"text":"These medicines block proteins that restrain immune responses","source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2019/cancer-immunotherapy-investigating-side-effects","host":"cancer.gov","quote":"Immune checkpoint inhibitors, for example, block proteins that help keep the immune response in check, such as CTLA-4, PD-1, or PD-L1 (a protein that PD-1 attaches to).","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-11","next_check_at":"2027-11-11","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"Blood tests","aliases":["Blood tests","blood test"],"kind":"lab","origin":[{"field":"preparation","text":"Blood tests including liver, kidney and thyroid"},{"field":"initial_assessment_documents","text":"Recent blood test results"},{"field":"packages","text":"Blood tests"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"PD-L1 test","aliases":["PD-L1 test","PD-L1 testing","PD-L1","biomarker testing (PD-L1)"],"kind":"lab","origin":[{"field":"preparation","text":"Confirm diagnosis and biomarker testing (e.g., PD-L1)"},{"field":"initial_assessment_documents","text":"Biomarker results such as PD-L1 or MSI"}],"what_it_checks":{"text":"Shows whether the tumor has enough target protein to benefit from immunotherapy","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"Your test results will show whether you have enough PD-L1 protein in your tumor for you to benefit from a specific immunotherapy medicine.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"type":"case","text":"If you have certain types of cancer","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"You may need a PD-L1 test if you've been diagnosed with certain types of cancer that commonly cause high PD-L1 levels.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"test_prep":{"text":"Preparation depends on how the tissue sample is taken","source":{"url":"https://medlineplus.gov/lab-tests/pdl1-immunotherapy-tests/","host":"medlineplus.gov","quote":"Preparations for your test depend on how your tissue sample will be taken.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}}},{"id":"T3","name":"Microsatellite instability test","aliases":["Microsatellite instability test","MSI","MSI testing"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Biomarker results such as PD-L1 or MSI"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"Liver function test","aliases":["Liver function test","liver function tests","liver tests","LFTs"],"kind":"lab","origin":[{"field":"preparation","text":"Blood tests including liver, kidney and thyroid"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"Kidney function test","aliases":["Kidney function test","kidney function tests","kidney tests","renal function test"],"kind":"lab","origin":[{"field":"preparation","text":"Blood tests including liver, kidney and thyroid"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Thyroid function test","aliases":["Thyroid function test","thyroid function tests","thyroid tests","TFTs"],"kind":"lab","origin":[{"field":"preparation","text":"Blood tests including liver, kidney and thyroid"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"Hepatitis screening test","aliases":["Hepatitis screening test","hepatitis screening","hepatitis"],"kind":"lab","origin":[{"field":"preparation","text":"Screen for hepatitis, HIV and tuberculosis"}],"what_it_checks":{"text":"It identifies hepatitis B or C status to help plan treatment","source":{"url":"https://www.cancer.gov/node/4199/syndication","host":"cancer.gov","quote":"Knowing whether a person has hepatitis B or C may help plan treatment.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"HIV test","aliases":["HIV test","Anti-HIV test","HIV screening"],"kind":"lab","origin":[{"field":"preparation","text":"Screen for hepatitis, HIV and tuberculosis"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T9","name":"Tuberculosis test","aliases":["Tuberculosis test","TB test","tuberculosis screening"],"kind":"lab","origin":[{"field":"preparation","text":"Screen for hepatitis, HIV and tuberculosis"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T10","name":"CT scan","aliases":["CT scan","CT","CT imaging","computed tomography scan"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent CT or PET imaging reports"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-16","next_check_at":"2027-11-16","version":2},"prep_in_advance":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"visit_and_day":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"technique_prices":{"status":"ok","checked_at":"2026-11-17","items":[{"country_iso":"AT","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":9000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"AT","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":10000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"AT","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":15000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"AZ","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"AZ","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"AZ","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"CN","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":2000,"source":"package","offers":1,"offer_id":"6a7c30b9d34db297d9083bb5"},{"country_iso":"CN","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":4500,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"CN","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":9000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"CZ","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":18000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"CZ","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":19000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"CZ","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":26000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"DO","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"DO","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"DO","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"EG","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":1600,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"EG","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":2200,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"EG","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":4000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"DE","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":12000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"DE","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":13000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"DE","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":19000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"GR","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"GR","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"GR","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"IN","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":6500,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"IN","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":7500,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"IN","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":10500,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"IL","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":3500,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"IL","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":4500,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"IL","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":9000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"IT","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":6500,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"IT","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":7500,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"IT","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":11000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"JP","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"JP","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"JP","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"LV","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"LV","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"LV","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"LT","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"LT","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"LT","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"MY","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":9000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"MY","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":10000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"MY","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":16000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"MX","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":5500,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"MX","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":6500,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"MX","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":10000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"MA","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"MA","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"MA","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"KR","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":9000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"KR","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":10000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"KR","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":16000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"ES","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":13556,"source":"package","offers":1,"offer_id":"63dbb2397e94b320d7053012"},{"country_iso":"ES","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":5000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"ES","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":12000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"CH","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"CH","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"CH","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":null,"source":"not_found"},{"country_iso":"TH","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":5900,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"TH","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":7000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"TH","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":11000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"TR","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":2500,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"TR","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":2800,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"TR","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":3500,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"UA","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":2600,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"UA","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":3200,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"UA","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":5000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"AE","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":9000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"AE","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":10500,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"AE","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":17000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"GB","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":60000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"GB","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":65000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"GB","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":85000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"US","technique_id":"pd-1-inhibitor-infusion","technique":"PD-1 inhibitor infusion (e.g., pembrolizumab, nivolumab)","currency":"USD","date":"2026-11-17","price_from":15000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"US","technique_id":"pd-l1-inhibitor-infusion","technique":"PD-L1 inhibitor infusion (e.g., atezolizumab, durvalumab)","currency":"USD","date":"2026-11-17","price_from":17000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"US","technique_id":"ctla-4-inhibitor-combination","technique":"CTLA-4 inhibitor combination (e.g., ipilimumab plus nivolumab)","currency":"USD","date":"2026-11-17","price_from":30000,"source":"estimate","model":"claude-sonnet-5-5"}]}}},"hrefLanguages":[{"rel":"alternate","hreflang":"ru","language":"ru","href":"https://ru.bookimed.com/clinics/country=kitaj/city=chendu/procedure=immunoterapiya/"}],"offerFilters":{"offer_count":1,"country_filter":[{"id":203,"name":"China","alias":"china","iso_code":"CN"}],"city_filter":[{"id":2693,"name":"Chengdu","alias":"chengdu","country_iso_code":"CN"},{"id":2015,"name":"Shanghai","alias":"shanghai","country_iso_code":"CN"}],"price_filter":{"from":2000,"to":2000,"avg":2000},"related_procedure_filter":[{"id":283,"name":"Immunotherapy","alias":"immunotherapy","illness_kind_ids":[10],"use_for_listing":true}],"popular_filter":["special_price"],"doctor_experience":["diapason_4"],"services":[{"id":"24-hr-nurse-services","type":"common","name":"24-hr nurse services"},{"id":"accommodation-is-not-included","type":"accommodation","name":"Accommodation is not included"},{"id":"transfer-is-not-included","type":"transfer","name":"Transfer is not included"}]},"offersBlock":{"operation_id":283,"operation_name":"Immunotherapy","country_name":"China","country_iso_code":"CN","seo_texts":{"base":"Base immunotherapy packages in China: currently no active offers listed on Bookimed. Explore our premium option or request updates as new affordable packages become available.","standard":"Standard immunotherapy packages in China currently unavailable on Bookimed. We will update this section as mid-range options appear. Meanwhile, consider the premium CAR-T therapy package for comprehensive diagnostics, hospitalization, medications, and follow-up care.","premium":"Premium CAR-T therapy in China: $100,000 package includes multi-specialist consultations (pediatric hematology, oncohematology), hospitalization, biopsy, ECG, ultrasound, CBC/biochemistry, urine tests, medications and post-op care with follow-ups. Consumables included. Transfer not included."},"prices_usd":{"base":{"min":0,"max":0,"median":0,"count":0},"standard":{"min":0,"max":0,"median":0,"count":0},"premium":{"min":100000,"max":100000,"median":100000,"count":1}}},"procedureTexts":[{"operation_id":491,"operation_info":{"id":491,"name":"Immunotherapy with Keytruda (Pembolizumab)","alias":"keytruda"},"texts":{"overview":{"text":"<h3>Immunotherapy with Keytruda (Pembolizumab)</h3> <p>Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.</p> <div>[icon-pros]<b>Pros:</b><span> Offers a targeted approach with fewer side effects; clinical trials show a 70% response rate in some cancers. Suitable for varied cancer types due to its immune modulation properties.</span></div> <div>[icon-cons]<b>Cons:</b><span> May cause immune-related adverse effects such as colitis or pneumonitis in up to 10% of patients. Limited effectiveness in tumors with low PD-L1 expression.</span></div> <div>[icon-effect]<b>Effectiveness:</b><span> 70% response rate in some cancer types.</span></div> <div>[icon-clock]<b>Duration:</b><span> Each session lasts about 30 minutes.</span></div> <div>[icon-run]<b>Recovery:</b><span> Not needed.</span></div> <div>[icon-thumbs]<b>Best for:</b><span> Cancers with high PD-L1 expression, melanoma, and non-small cell lung cancer.</span></div> <div>[icon-price]<b>Prices:</b><span> [txt-country]</span></div>"},"txt_short":{"text":"<p>The therapy is a treatment enhancing the body\"s immune system to fight cancer, using a drug highly targeted and effective.</p>"}}}],"rendersOffersList":false,"fewClinics":true,"topCountriesCount":0}